Page 9 - Activating Construct News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Activating construct. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Activating Construct Today - Breaking & Trending Today

500.com Reiterates "Reiterates" Rating for Harpoon Therapeutics (NASDAQ:HARP)

Harpoon Therapeutics (NASDAQ:HARP – Get Rating)‘s stock had its “reiterates” rating reiterated by equities research analysts at 500.com in a note issued to investors on Monday, Benzinga reports. Several other analysts also recently weighed in on the company. HC Wainwright dropped their price objective on Harpoon Therapeutics from $7.00 to $4.50 and set a “buy” […] ....

United Kingdom General , United Kingdom , Ronald Hunt , Harpoon Therapeutics Company Profile , Blackrock Inc , Renaissance Technologies , Vanguard Group Inc , Sequoia Financial Advisors , Canaccord Genuity Group , Harpoon Therapeutics Inc , Dimensional Fund Advisors , Harpoon Therapeutics , Get Rating , Genuity Group , Director Ronald Hunt , Fund Advisors , Financial Advisors , Activating Construct , Harpoon Therapeutics Daily , Nasdaq Harp , Reiterated Rating , 500 Com Limited ,

Harpoon Therapeutics, Inc. (NASDAQ:HARP) Short Interest Update

Harpoon Therapeutics, Inc. (NASDAQ:HARP – Get Rating) was the recipient of a large growth in short interest in April. As of April 30th, there was short interest totalling 761,200 shares, a growth of 115.5% from the April 15th total of 353,200 shares. Based on an average daily trading volume, of 305,500 shares, the short-interest ratio […] ....

United States , Ronald Hunt , Prudential Financial Inc , Delphia United States Inc , Canaccord Genuity Group , Sequoia Financial Advisors , Harpoon Therapeutics Inc , Harpoon Therapeutics , Get Rating , Director Ronald Hunt , Financial Advisors , Sigma Investments , Prudential Financial , Genuity Group , Activating Construct , Harpoon Therapeutics Daily , Nasdaq Harp ,

Harpoon Therapeutics, Inc. (NASDAQ:HARP) Short Interest Up 115.5% in April

Harpoon Therapeutics, Inc. (NASDAQ:HARP – Get Rating) saw a significant increase in short interest in April. As of April 30th, there was short interest totalling 761,200 shares, an increase of 115.5% from the April 15th total of 353,200 shares. Currently, 3.3% of the company’s stock are sold short. Based on an average daily volume of […] ....

Ronald Hunt , Harpoon Therapeutics Inc , Securities Exchange Commission , Renaissance Technologies , Millennium Management , Harpoon Therapeutics Company Profile , Blackrock Inc , Canaccord Genuity Group , Piper Sandler , Harpoon Therapeutics , Get Rating , Director Ronald Hunt , Exchange Commission , Genuity Group , Activating Construct , Harpoon Therapeutics Daily , Nasdaq Harp ,

Harpoon Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update

Harpoon Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Julie Eastland , Roberth Uhl , Harpoon Therapeutics Inc , Harpoon Development , Exchange Commission , American Society Of Hematology , Chief Executive Officer , Activating Construct , American Society , Annual Meeting , Five Preclinical Posters Presented , Restated Collaboration Agreement , Option Agreement , Harpoon Therapeutics , Private Securities Litigation Reform Act , Harpoon Therapeutic , Three Months ,

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

United States , Roberth Uhl , Julie Eastland , American Society Of Hematology , Exchange Commission , Harpoon Development , Harpoon Therapeutics Inc , Chief Executive Officer , Activating Construct , American Society , Annual Meeting , Five Preclinical Posters Presented , Restated Collaboration Agreement , Option Agreement , Harpoon Therapeutics , Private Securities Litigation Reform Act , Harpoon Therapeutic , Three Months ,